High-risk behaviours and concomitant medical illnesses among patients at Methadone Maintenance Theraphy Clinic, Hospital Tengku Ampuan Afzan, Malaysia
Background: High prevalence of high-risk behaviours and concurrent medical illnesses among opioid drug users wouldinfluence the outcome of Methadone Maintenance Programme. It would also require a special medical attention tocontain these issues. Objectives: This study explored patients’ characteristics and their high-risk behaviours in orderto understand more about opioid dependent users in Malaysia.
Methods: A total of 172 patient case notes at Methadone Clinic Hospital Tengku Ampuan Afzan (HTAA) were retrievedfor relevant data.
Results: Many of the patients were engaged in high-risk behaviours such as needle sharing, unsafe sex and criminalactivities. A large number of the subjects had contracted blood-borne diseases such as HIV and hepatitis infections.
Conclusions: Education on the issue of medical and psychosocial complications related to high risk behaviours isessential. Medical professionals dealing with this group have to pay attention and update their knowledge on the medicalissue.
Yaacob S, Kazidi MZ. Buletin AADK. 1st ed. Kuala Lumpur: Agensi Anti Dadah Kebangsaan; 2008. Available from: URL: http://www.adk.gov.my/modules/xt_conteudo/index.php?id=226.
Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses. Int J Drug Policy. 2007;18(2):136-40.
National Methadone Maintenance Therapy Guidelines. Putrajaya: Ministry of Health Malaysia; 2005.
Darke S, Ward J, Hall W, et al. The Opiate Treatment Index (OTI) Researcher’s Manual. National Drug and Alcohol Research Centre Technical Report Number 11. Sydney: National Drug and Alcohol Research Centre, 1991.
Noor Zurani MHR, Hussain H, Rusdi AR, et al. Heroin addiction: the past and future. Malaysian Journal of Psychiatry. 2009;17(2):73-8.
Gong AWH, Ng CG, Amer SAN, et al. Quality of life assessment of opioid substance abusers on methadone maintenance therapy (MMT) in University Malaya Medical Centre. ASEAN Journal of Psychiatry. 2009;10:1.
Kleber HD. Methadone maintenance 4 decades later, thousands of lives saved but still controversial. JAMA. 2008;300(19):2303-5.
Shellard EJ. The alkaloids of Mitragyna with special reference to those of Mitragyna speciosa, Korth. Bull Narc. 1974;26(2): 41-55.
Singh S, Crofts N. HIV infection among injecting drug users in north east Malaysia, 1992. AIDS Care. 1993;5(3):273-81.
Ramli H, Maniam T, Chin CN, et al. Heroin dependence and HIV infection: a review of the factors influencing HIV risktaking behaviour. Malaysian Journal of Psychiatry. 1996;4(2):15-24.
Jesjeet SG, Hatim AS, Hussain MH. The first methadone programme in Malaysia: overcoming obstacles and achieving the impossible. ASEAN Journal of Psychiatry. 2007;8(2):64-70.
Dickinson GL, Rostami-Hodjegan A, Lagundoye O, et al. A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK. J Clin Pharm Ther. 2006;31(5):477-84.
Mutasa HCF. Risk factors associated with non compliance with methadone substitution therapy (MST) and relapse among chronic opiate users in an Outer London community. J Adv Nurs. 2001;35(1):97-107.
WHO, UNAIDS, UNODC. Evidence for action on HIV/AIDS and injecting drug use policy brief: Provision of sterile injecting equipment to reduce HIV transmission. World Health Organization; 2004.